Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)

DB10991ApprovedInvestigationalVaccinesInactivated Bordetella Pertussis Vaccine

Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) is a vaccine that is used in the prophylaxis of Pertussis (whooping cough), which is caused by a small Gram-negative coccobacillus that infects...

First approval
Canada, 2001 · United States, 2008
Also known as
Bordetella pertussis toxoid vaccine, inactivated · Pertussis toxoid
Brand names
  • Adacel
  • Boostrix
  • Infanrix
  • Kinrix
  • Pediarix
  • Pentacel
  • Quadracel

Resolves to

Compound
UNIIQSN5XO8ZSU
Clinical / RWD
RxNorm1300186

What you can answer from here — as of April 02, 2025

289Drug interactionsStructured to mechanism, not free text
Sign in
143Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
106Marketed productsAcross 8 countries and 13 labellers
Sign in

Which other approved drugs treat the same conditions as Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated), and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In